RNA的尿苷化

很多RNA分子可以进行转录后修饰.最近的研究发现,末端无需模板的尿苷酸添加(尿苷化)可能就是一种广泛存在且保守,但以前了解甚少的RNA转录后修饰方式.这种修饰可以发生在从藻类到人类的很多RNA上,如多聚腺苷化的mRNA、siRNAs或miRNAs内切mRNA得到的上游片段、组蛋白mRNA、目前发现的大多数小调节RNAs、U6小核RNA(snRNA)、转录起点相关的小RNA和剪切的内含子等.这种修饰不仅具有重要的功能,如增强RNA的降解、促进或抑制RNA的加工形成、改变RNA的活性或作为mRNA的一种质量控制机制,而且还与人类的一些致病机制有关,如癌症.本文主要综述了小RNA、mRNA及其内切片段、组蛋白mRNA和U6 snRNA等RNA尿苷化的研究进展,并对相关研究的应用前景做了展望.     

miRNA的异构体——isomiR

最近,深度测序技术揭示:同一个miRNA前体可能由于Drosha或Dicer的剪切位点改变,外切核酸酶介导的miRNA末端缩短,miRNA编辑或miRNA 3'末端无需模板的核苷酸添加等4种原因,而形成多种长度或序列不同的miRNAs异构体—isomiR.因为这些isomiR与已注解的miRNA可以调节同一个靶标,也可以靶向不同的靶标,所以它们不仅扩大了miRNA调节的范围,而且还有可能代表了每种miRNA基于isomiR的一种微型调节网络.研究发现,isomiR的表达具有细胞、组织、发育和疾病状况等特异性,并且很多人类疾病的致病机制也与它们有关,推测isomiR将来不仅有可能成为疾病诊断或治疗的生物学标记或靶标,而且相关的研究还对于RNA干扰技术也具有重要的指导意义.本文主要综述了isomiR的研究进展,并对isomiR应用前景做了展望.     

3'-端尿苷酸化引发RNA降解的机制

RNA末端的转录后修饰对其稳定性影响较大.最近研究发现,3'-末端无需模板的添加尿苷酸(尿苷酸化),可能是真核生物RNA的一种普遍存在的转录后修饰方式.借此形成的1个RNA降解的分子标记,引发多种RNA降解,如小RNA或其前体、mRNA或mRNA被RNA诱导沉默复合体内切后的上游片段及其组蛋白mRNA等.某些情况下,尿苷酸化的RNA被1种新发现的外切核酸酶Dis3L2特异降解,推测Dis3L2可能代表了真核生物RNA 3'→5'方向独立于外切体之外的一种新的降解途径.此外,尿苷酸化在RNA代谢中可能具有重要的功能,如果发生异常会导致多种人类疾病,如癌症和Perlman综合征等.本文综述了尿苷酸化引发RNA降解的几种方式,有助于进一步了解RNA降解的机制及其生物学意义.     

尿苷酸化：一种重要的细胞内RNA监控方式

RNA尿苷酸化作为一种高效的转录后基因调控方式，几乎存在于所有的真核生物中。末端尿苷酸转移酶(terminal uridylyltransferase, TUTase)负责催化生物体内snRNA、miRNA、mRNA和其他ncRNA的单尿苷酸化(monouridylation)和寡尿苷酸化(oligouridylation)。研究表明，对非编码RNA中间产物的单尿苷酸化可以改变其最终产物和生成速度，而寡尿苷酸化常用于时空特异性降解特定RNA、清除质量异常的RNA和病毒RNA。尿苷酸化通过这两种方式调控RNA的生成和降解，进而影响生物的生殖和早期发育、细胞凋亡、肿瘤发生以及病毒感染等多个重要的生物过程。本文对尿苷酸化的现有研究成果进行综述，介绍了RNA 3′末端检测技术，重点阐述了尿苷酸化调控基因表达的分子机制和其在RNA监控以及多种生物过程中的关键性作用，最后讨论了待解决的科学问题和未来研究的重要方向，旨在为抗病毒和抗肿瘤的临床治疗提供新思路。     

S-谷胱甘肽化修饰的研究进展

S-谷胱甘肽化(S-glutathionylation)是谷胱甘肽和靶蛋白半胱氨酸残基之间形成混合二硫化物的过程.由于其能调节靶蛋白功能,因此也属于蛋白质翻译后修饰.与其相对应,蛋白质的去谷胱甘肽化可由谷氧还蛋白(Grx)催化.因此,S-谷胱甘肽化修饰也被认为是一种防止蛋白质半胱氨酸巯基发生不可逆修饰的保护机制.由于该修饰还会改变含有巯基的氧化还原敏感型蛋白的结构与功能,因此也属于蛋白质功能调节的重要方式.哺乳动物细胞中S-谷胱甘肽化水平的改变与许多病理机制有关,但S-谷胱甘肽化在植物中的研究还处于起步阶段.本文综述了蛋白质的S-谷胱甘肽化的反应机制、检测方法、生理作用的相关研究进展,最后还提出今后研究中要解决的重要问题.     

天然反义转录物及其调控基因的表达机制

天然反义转录(NATs)是一组编码蛋白质或非编码蛋白质的RNAs, 与其他(有义)转录物具有互补序列, 可以调节有义链的表达。这种调节可以发生在转录水平或转录后水平, 调节方式有转录干扰、RNA封闭、双链依赖机制或染色质重建(修饰)等。正义链和反义链分别加工成小RNAs调节基因表达, 也是NATs调节基因表达的重要方式, 如piRNAs的“乒乓机制”。实验或计算机研究已经证明了NATs在生物中广泛存在, 是一种重要的基因表达调节方式。文章论述了NATs的重要作用和机理, 重点论述了NATs的调节机制和相关的小RNAs。     

MicroRNA在脂肪细胞分化中的调节作用

MicroRNA(miRNA)是一类内源性、短小、大小为～22核苷酸的单链非编码RNA.miRNA广泛分布于真核细胞内,能够通过与靶mRNA3'末端非翻译区(3'-untranslated region,3'UTR)特异性结合来降解或抑制靶mRNA的翻译,从而对基因进行转录后基因表达的调控.miRNA不仅调控生物体的生长和发育过程,而且参与调控多种生理学和病理学过程,如细胞分化、细胞增殖、胰岛素的分泌、脂肪代谢以及肿瘤的形成.研究表明miRNA在肿瘤、糖尿病、代谢等多种疾病中发挥着重要的作用.本文对miRNA在脂肪细胞分化及脂类代谢中的调节作用进行综述.     

组蛋白的泛素化与去泛素化修饰

泛素在真核生物体内广泛存在,泛素化修饰是转录后的修饰方式之一;组蛋白是染色质的主要成分之一,与基因的表达有密切关系。组蛋白的泛素化修饰与经典的蛋白质的泛素调节途径不同,不会导致蛋白质的降解,但是能够招募核小体到染色体、参与X染色体的失活、影响组蛋白的甲基化和基因的转录。组蛋白的去泛素化修饰同样与染色质的结构及基因表达密切相关。组蛋白的泛素化和磷酸化、乙酰化、甲基化修饰之间还存在协同和级联效应。     

miRNA的生物形成及调控基因表达机制

微RNA(microRNA,miRNA)通过调节靶基因的表达水平影响细胞分化、增殖、凋亡等特性,在生物的生长发育和疾病发生发展中发挥重要的作用。将miRNA用于基因功能研究,药物靶点验证,基因治疗等领域有非常好的前景。揭示miRNA的生成和加工过程以及miRNA调节靶基因基因表达水平的作用机制对于阐述miRNA在生理病理过程中的作用有重要意义。因此,本文对miRNA的发生,成熟以及作用机制的研究进展作综述。     

SUMO化信号途径对JNK信号通路活性的调控

c-Jun氨基末端激酶(the c-Jun N-terminal kinase,JNK)家族是促分裂原活化蛋白激酶(MAPK)超家族成员之一.JNK信号通路对细胞生长、分化和凋亡等生物学活动都有重要作用.而SUMO化是一种重要的生物学修饰,可以调节多种细胞生理活动.最近,黄海等在Development发表文章首次将SUMO化途径与JNK信号通路通过Hipk激酶联系起来,为进一步研究SUMO化的功能及其对JNK通路的调节建立了一个新的模型.     

植物成熟microRNA转录后修饰与降解的研究进展

microRNA(miRNA)是一类长度为20–24 nt的内源小RNA,广泛存在于各种植物体内,参与调控植物器官的形态建成、激素应答、逆境胁迫和营养代谢等一系列过程。虽然miRNA生物合成和功能研究已取得了很大进展,但关于植物成熟miRNA的转录后修饰和降解的研究却报道较少。一方面miRNA如同其它RNA存在半衰期,其降解对于调控细胞内miRNA含量起重要作用,从而调控植物的生长发育或胁迫响应等过程;另一方面,成熟miRNA存在转录后修饰,可影响miRNA的稳定性,最终影响其活性。该文着重从植物成熟miRNA的转录后修饰和降解等方面进行了综述。     

Selective microRNA uridylation by Zcchc6 (TUT7) and Zcchc11 (TUT4)

Recent small RNA sequencing data has uncovered 3′ end modification of mature microRNAs (miRNAs). This non-templated nucleotide addition can impact miRNA gene regulatory networks through the control of miRNA stability or by interfering with the repression of target mRNAs. The miRNA modifying enzymes responsible for this regulation remain largely uncharacterized. Here we describe the ability for two related terminal uridyl transferases (TUTases), Zcchc6 (TUT7) and Zcchc11 (TUT4), to 3′ mono-uridylate a specific subset of miRNAs involved in cell differentiation and Homeobox (Hox) gene control. Zcchc6/11 selectively uridylates these miRNAs in vitro, and we biochemically define a bipartite sequence motif that is necessary and sufficient to confer Zcchc6/11 catalyzed uridylation. Depletion of these TUTases in cultured cells causes the selective loss of 3′ mono-uridylation of many of the same miRNAs. Upon TUTase-dependent loss of uridylation, we observe a concomitant increase in non-templated 3′ mono-adenylation. Furthermore, TUTase inhibition in Zebrafish embryos causes developmental defects and aberrant Hox expression. Our results uncover the molecular basis for selective miRNA mono-uridylation by Zcchc6/11, highlight the precise control of different 3′ miRNA modifications in cells and have implications for miRNA and Hox gene regulation during development.     

Mammalian DIS3L2 exoribonuclease targets the uridylated precursors of let-7 miRNAs

The mechanisms of gene expression regulation by miRNAs have been extensively studied. However, the regulation of miRNA function and decay has long remained enigmatic. Only recently, 3′ uridylation via LIN28A-TUT4/7 has been recognized as an essential component controlling the biogenesis of let-7 miRNAs in stem cells. Although uridylation has been generally implicated in miRNA degradation, the nuclease responsible has remained unknown. Here, we identify the Perlman syndrome-associated protein DIS3L2 as an oligo(U)-binding and processing exoribonuclease that specifically targets uridylated pre-let-7 in vivo. This study establishes DIS3L2 as the missing component of the LIN28-TUT4/7-DIS3L2 pathway required for the repression of let-7 in pluripotent cells.     

Zcchc11 Uridylates Mature miRNAs to Enhance Neonatal IGF-1 Expression,Growth, and Survival

The Zcchc11 enzyme is implicated in microRNA (miRNA) regulation. It can uridylate let-7 precursors to decrease quantities of the mature miRNA in embryonic stem cell lines, suggested to mediate stem cell maintenance. It can uridylate mature miR-26 to relieve silencing activity without impacting miRNA content in cancer cell lines, suggested to mediate cytokine and growth factor expression. Broader roles of Zcchc11 in shaping or remodeling the miRNome or in directing biological or physiological processes remain entirely speculative. We generated Zcchc11-deficient mice to address these knowledge gaps. Zcchc11 deficiency had no impact on embryogenesis or fetal development, but it significantly decreased survival and growth immediately following birth, indicating a role for this enzyme in early postnatal fitness. Deep sequencing of small RNAs from neonatal livers revealed roles of this enzyme in miRNA sequence diversity. Zcchc11 deficiency diminished the lengths and terminal uridine frequencies for diverse mature miRNAs, but it had no influence on the quantities of any miRNAs. The expression of IGF-1, a liver-derived protein essential to early growth and survival, was enhanced by Zcchc11 expression in vitro, and miRNA silencing of IGF-1 was alleviated by uridylation events observed to be Zcchc11-dependent in the neonatal liver. In neonatal mice, Zcchc11 deficiency significantly decreased IGF-1 mRNA in the liver and IGF-1 protein in the blood. We conclude that the Zcchc11-mediated terminal uridylation of mature miRNAs is pervasive and physiologically significant, especially important in the neonatal period for fostering IGF-1 expression and enhancing postnatal growth and survival. We propose that the miRNA 3′ terminus is a regulatory node upon which multiple enzymes converge to direct silencing activity and tune gene expression.     

Methylation protects miRNAs and siRNAs from a 3'-end uridylation activity in Arabidopsis

Small RNAs of 21-25 nucleotides (nt), including small interfering RNAs (siRNAs) and microRNAs (miRNAs), act as guide RNAs to silence target-gene expression in a sequence-specific manner. In addition to a Dicer homolog, DCL1, the biogenesis of miRNAs in Arabidopsis requires another protein, HEN1. miRNAs are reduced in abundance and increased in size in hen1 mutants. We found that HEN1 is a miRNA methyltransferase that adds a methyl group to the 3'-most nucleotide of miRNAs, but the role of miRNA methylation was unknown. Here, we show that siRNAs from sense transgenes, hairpin transgenes, and transposons or repeat sequences, as well as a new class of siRNAs known as trans-acting siRNAs, are also methylated in vivo by HEN1. In addition, we show that the size increase of small RNAs in the hen1-1 mutant is due to the addition of one to five U residues to the 3' ends of the small RNAs. Therefore, a novel uridylation activity targets the 3' ends of unmethylated miRNAs and siRNAs in hen1 mutants. We conclude that 3'-end methylation is a common step in miRNA and siRNA metabolism and likely protects the 3' ends of the small RNAs from the uridylation activity.     

PPR polyadenylation factor defines mitochondrial mRNA identity and stability in trypanosomes

In Trypanosoma brucei, most mitochondrial mRNAs undergo internal changes by RNA editing and 3′ end modifications. The temporally separated and functionally distinct modifications are manifested by adenylation prior to editing, and by post‐editing extension of a short A‐tail into a long A/U‐heteropolymer. The A‐tail stabilizes partially and fully edited mRNAs, while the A/U‐tail enables mRNA binding to the ribosome. Here, we identify an essential pentatricopeptide repeat‐containing RNA binding protein, kinetoplast polyadenylation factor 3 (KPAF3), and demonstrate its role in protecting pre‐mRNA against degradation by the processome. We show that KPAF3 recruits KPAP1 poly(A) polymerase to the 3′ terminus, thus leading to pre‐mRNA stabilization, or decay depending on the occurrence and extent of editing. In vitro, KPAF3 stimulates KPAP1 activity and inhibits mRNA uridylation by RET1 TUTase. Our findings indicate that KPAF3 selectively directs pre‐mRNA toward adenylation rather than uridylation, which is a default post‐trimming modification characteristic of ribosomal and guide RNAs. As a quality control mechanism, KPAF3 binding ensures that mRNAs entering the editing pathway are adenylated and, therefore, competent for post‐editing A/U‐tailing and translational activation.